Here's some discuss and news regarding actizapharma which are working on the contract pharmaceutical production worldwide. They proficient enough to customize the entire range of medicines, to meet client’s requirements.
Advances and investment in digital health is growing at an incredible rate and Contract Manufacturing Organizations and Contract Development and Manufacturing Organizations are becoming an essential part of the new pharma value chain. From wearables, to apps, to digital platforms, the data and efficiencies generated by these innovations are opening up important avenues across the pharma ecosystem. As pressure on improving drug development heats up, data, digital and technological innovations are critical to delivering the desired business and patient outcomes, promoting significantly more networking and outsourcing strategies. CMOs are evolving from service providers to strategic partners. CMOs now cover the entire value chain of pharma production, including specialized services such as R&D.
This research service provides an in-depth analysis of the global pharmaceutical contract manufacturing market with particular focus on the finished dose formulations such as solid, liquid and semi-solid, and injectable dose formulations. Segment analysis, trends and revenue forecast for the global, U.S. and European regions have been provided in detail. Strategic recommendations for the success of market participants have also been discussed.
A brief introduction of the outsourcing methods in Pharma Supply Chain, Types of Outsourcing, Framework to decide correct outsourcing partner, factors to consider while selecting a partner, Process of outsourcing and Outsourcing models.
Fostering the Quality Based CMO-Sponsor RelationshipAjinomoto Althea
Althea Technologies' Sr. VP of Quality and Regulatory, EJ Brandreth, talks about life in the CMO world from the quality perspective. In this presentation, he discusses the regulations involved in biologics manufacturing and fill finish operations, and the importance of establishing a quality based partnership between CMOs and sponsors.
Advances and investment in digital health is growing at an incredible rate and Contract Manufacturing Organizations and Contract Development and Manufacturing Organizations are becoming an essential part of the new pharma value chain. From wearables, to apps, to digital platforms, the data and efficiencies generated by these innovations are opening up important avenues across the pharma ecosystem. As pressure on improving drug development heats up, data, digital and technological innovations are critical to delivering the desired business and patient outcomes, promoting significantly more networking and outsourcing strategies. CMOs are evolving from service providers to strategic partners. CMOs now cover the entire value chain of pharma production, including specialized services such as R&D.
This research service provides an in-depth analysis of the global pharmaceutical contract manufacturing market with particular focus on the finished dose formulations such as solid, liquid and semi-solid, and injectable dose formulations. Segment analysis, trends and revenue forecast for the global, U.S. and European regions have been provided in detail. Strategic recommendations for the success of market participants have also been discussed.
A brief introduction of the outsourcing methods in Pharma Supply Chain, Types of Outsourcing, Framework to decide correct outsourcing partner, factors to consider while selecting a partner, Process of outsourcing and Outsourcing models.
Fostering the Quality Based CMO-Sponsor RelationshipAjinomoto Althea
Althea Technologies' Sr. VP of Quality and Regulatory, EJ Brandreth, talks about life in the CMO world from the quality perspective. In this presentation, he discusses the regulations involved in biologics manufacturing and fill finish operations, and the importance of establishing a quality based partnership between CMOs and sponsors.
Global supply chain in ranbaxy paonta sahib manufacturing facilityAnkur Srivastava
This is a project report made by me on the Global Supply Chain Process of Ranbaxy Laboratories Ltd., one of the world's largest Pharmaceutical Manufacturers; and its impact on its Global Business. The related study was done in the year 2011 and report was prepared then.
Future Pharma Trends - Long-term opportunities tempered by short-term challengesscottosur
An overview of the key trends shaping the pharmaceutical industry today, and those that are set to play a central role in the future, as companies transition towards a new business model: Pharma 2.0.
Provides key strategies and trends shaping the future of the pharmaceutical industry. Examines the impact of the Obama administration on US healthcare, and the implications for Pharma. Assesses the implications of the current economic and financial situation on healthcare. Analyzes key growth drivers and resistors set to shape Pharma\'s future.
Contact me at sosur@datamonitor.com to learn more!
At the 2011 Partnership for Safe Medicines Interchange conference, Mike Levy from the US Food and Drug Administration talked about the FDA's efforts to secure the pharmaceutical supply chain.
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply ChainLaura Olson
The pharmaceutical industry is undergoing tremendous changes. Numerous forces are re-shaping the new pharmaceutical ecosystem. Technology, demographics, regulations and shifts in wealth are creating transformative change. Increasingly becoming a more patient-centric world, patients use Smart devices to monitor research and evaluate pharmaceutical products. Healthcare reform regulations, the devaluation of the existing pharma model and trend towards patient empowerment and access to information are shaping the changing pharma industry, much as the retail industry was shaped by the multichannel and omni channel retailing trends of recent years. Regulators have become increasingly more cautious when improving innovative medicines. As pharmaceuticals have become more successful in prolonging life and treating illness, many medical conditions are now chronic. Today healthcare providers have become increasingly interested in measuring the outcomes of pharma performance and basing pricing accordingly. There has been a dramatic increase in prescription volume and an increased production and use of generic drugs. Producing pharmaceuticals in other countries can be complicated. Customs, local regulations and other factors impact products and require brands to adapt. Generic pharmaceuticals are becoming the dominant category globally, especially in developing rather than just industrial countries. Adding to the complexity, a large number of pharmaceutical products are made by multiple countries. These factors and the move towards specialty pharmaceuticals and greater production of pharmaceutical products globally have resulted in more pressure on global supply chains. Because supply chains have moved from local to global in operation, even one significant event can interrupt the global supply chain. Events such as hurricanes and typhoons, earthquakes, political and economic upheaval can have serious impacts on global supply chains, adding unforeseen costs and delays. Health care reform magnifies the effect of longer supply chains and increases the intense cost pressure on drug manufacturers. In order to reduce costs, more production as well as research and development are being offshored and outsourced.
Risk management in pharmaceutical supply chainMohammad Fat'hy
In the modern day, a company's competitive advantage in most industries will be determined by maximizing its relationships and the diligent management of its forward and backwards facing supply chains.
The ability to effectively manage risks in a supply chain is an absolute must in the skill set of any current supply chain professional. This course will equip and develop procurement and supply chain professionals to be able to operate diligently and effectively with their supply base, mitigating any risks and maximizing all opportunities to gain competitive advantage in their market place.
Global supply chain in ranbaxy paonta sahib manufacturing facilityAnkur Srivastava
This is a project report made by me on the Global Supply Chain Process of Ranbaxy Laboratories Ltd., one of the world's largest Pharmaceutical Manufacturers; and its impact on its Global Business. The related study was done in the year 2011 and report was prepared then.
Future Pharma Trends - Long-term opportunities tempered by short-term challengesscottosur
An overview of the key trends shaping the pharmaceutical industry today, and those that are set to play a central role in the future, as companies transition towards a new business model: Pharma 2.0.
Provides key strategies and trends shaping the future of the pharmaceutical industry. Examines the impact of the Obama administration on US healthcare, and the implications for Pharma. Assesses the implications of the current economic and financial situation on healthcare. Analyzes key growth drivers and resistors set to shape Pharma\'s future.
Contact me at sosur@datamonitor.com to learn more!
At the 2011 Partnership for Safe Medicines Interchange conference, Mike Levy from the US Food and Drug Administration talked about the FDA's efforts to secure the pharmaceutical supply chain.
The New Pharma Ecosystem: 2014 Trends Reshaping the Pharmaceutical Supply ChainLaura Olson
The pharmaceutical industry is undergoing tremendous changes. Numerous forces are re-shaping the new pharmaceutical ecosystem. Technology, demographics, regulations and shifts in wealth are creating transformative change. Increasingly becoming a more patient-centric world, patients use Smart devices to monitor research and evaluate pharmaceutical products. Healthcare reform regulations, the devaluation of the existing pharma model and trend towards patient empowerment and access to information are shaping the changing pharma industry, much as the retail industry was shaped by the multichannel and omni channel retailing trends of recent years. Regulators have become increasingly more cautious when improving innovative medicines. As pharmaceuticals have become more successful in prolonging life and treating illness, many medical conditions are now chronic. Today healthcare providers have become increasingly interested in measuring the outcomes of pharma performance and basing pricing accordingly. There has been a dramatic increase in prescription volume and an increased production and use of generic drugs. Producing pharmaceuticals in other countries can be complicated. Customs, local regulations and other factors impact products and require brands to adapt. Generic pharmaceuticals are becoming the dominant category globally, especially in developing rather than just industrial countries. Adding to the complexity, a large number of pharmaceutical products are made by multiple countries. These factors and the move towards specialty pharmaceuticals and greater production of pharmaceutical products globally have resulted in more pressure on global supply chains. Because supply chains have moved from local to global in operation, even one significant event can interrupt the global supply chain. Events such as hurricanes and typhoons, earthquakes, political and economic upheaval can have serious impacts on global supply chains, adding unforeseen costs and delays. Health care reform magnifies the effect of longer supply chains and increases the intense cost pressure on drug manufacturers. In order to reduce costs, more production as well as research and development are being offshored and outsourced.
Risk management in pharmaceutical supply chainMohammad Fat'hy
In the modern day, a company's competitive advantage in most industries will be determined by maximizing its relationships and the diligent management of its forward and backwards facing supply chains.
The ability to effectively manage risks in a supply chain is an absolute must in the skill set of any current supply chain professional. This course will equip and develop procurement and supply chain professionals to be able to operate diligently and effectively with their supply base, mitigating any risks and maximizing all opportunities to gain competitive advantage in their market place.
Presentation given by Tarun Agarwal to Indian Merchants Chamber (IMC), India's foremost think-tank, on Economic Development for Small & Medium Entreprises (SMEs).
Do read, you will surely find some aspects of it provocative.
It tries to showcase also the need to have an integrated economic development plan where all segments of society work together - Can the SMEs succeed without the support of its employees, vendors, information technology, big businesses, government agencies? The answer is no.
Icon Business Forum is has mobilized of strategy consultants, investment bankers, celebrities, writers, industry chambers to usher in a wave of collective economic development.
Contract Theory - The Nobel Prize in Economic Sciences 2016CLO Legal Solutions
Contract theory does not necessarily provide definitive or unique answers to these questions, as the
best contract will typically depend on the specific situation and context. However, the power of the
theory is that it enables us to think clearly about the issues involved. The contributions of this year’s
laureates, Oliver Hart and Bengt Holmström, are invaluable in helping us understand real-life contracts
and institutions, as well as the potential pitfalls when designing new contracts.
Law Firm in Tirana Albania
www.cenameri.com
info@cenameri.com
Cryptocurrencies, Smart Contracts, and the Future of Economic InteractionSteve Omohundro
Contracts are society's programming language. Corporations are defined by contracts with investors, employees, customers, etc. Countries are defined by social contracts with citizens, representatives, corporations, etc. But today's contracts are confusing and expensive to create and enforce. They are written in bad programming languages and enforced by slow, complex, expensive, and unpredictable mechanisms.
In 1993, Nick Szabo proposed machine executable "Smart Contracts" which can be self-enforcing. The introduction of the "Bitcoin" cryptocurrency in 2008 provided the decentralized "blockchain" infrastructure for implementing these smart contracts. Bitcoin spawned over 500 alternative "altcoin" cryptocurrencies and they have generated both enormous interest and huge volatility.
New "Bitcoin 2.0" technologies like Ethereum are just about to be released. These will support powerful smart contracting mechanisms and may transform many areas of human interaction. We describe these new technologies and their connection to the "Internet of Things" and emerging AI systems.
http://steveomohundro.com/2015/02/04/fuji-xerox-talk-cryptocurrencies-smart-contracts-and-the-future-of-economic-interaction/
An introduction to psychological contracts and how they can hurt or improve your organisation. This explains that the PC is about the emotional rather than the contractual relationship.
The process of defining a roadmap is arguably one of the most difficult but important things a product manager has to do. Far too often roadmaps are built without the complete picture in mind, without the right timing, in silos, or are misdirected. How then can we ensure we’re doing it right? Is there really such a thing as an agile roadmap?
This talk will draw from lessons learnt building product to provide practical tips and techniques enabling you to understand roadmap inputs, plan with different perspectives in mind, optimise for learning, communicate and set roadmap goals as well as find agility when the landscape around you changes.
Products covered:
Confluence
Pre-Launch Planning: Priming Your Pharma Brand For Profit And Success (mini)Eularis
In today’s environment, Pharmaceutical companies find themselves in a bind. Until recently, if drugs made over $500 Million in annual revenue within 3 to 5 years of launch, they were considered hugely successful. They were a support to an extensive company portfolio and a component of greater company profit.
However, things have changed. The standards for a successful drug have become much higher and much more dangerous. With so many revenue-producing drugs going off patent, companies are facing large holes in their balance sheets and sales that are increasingly slow.
Plus, with the stakes high and available funds low, pipelines are drying up. Add to this the closer scrutiny of safety issues, the rise of Generics, slower physician acceptance and adoption of new therapies, and the Pharma Industry is in trouble.
More and more, companies are expecting marketers to be instrumental at the key moment of launch, and marketers are under extreme pressure. To deliver on the high hopes of Pharmaceutical brand launch, companies must engage in comprehensive pre-launch planning.
In this report we analyze why launch is increasingly important, the issues involved in pre-launch planning, including key organizational strategies, marketing tactics, regulatory considerations, global issues, and methods for ensuring the most effective plans.
Things To Consider While Choosing Pharmaceutical Contract Manufacturers For L...Aliyan Pharmaceuticals
Explore key considerations for selecting a pharmaceutical contract manufacturer in Libya. Learn about the benefits, factors, and expert guidance.
https://aliyanpharma.com/things-to-consider-while-choosing-pharmaceutical-contract-manufacturers-for-libya/
Pharma contract manufacturing companies in india AditiMehra14
Want the best Pharma Contract Manufacturing Company? Find List of top pharmaceutical contract manufacturing companies in India at PharmaAdda. Visit http://www.pharmaadda.in/pharma-contract-manufacturing-companies-in-india
Pharma third party manufacturing companies in Baddi | PharmaaddaAditiMehra14
Looking for the best Pharma third Party Manufacturing Companies in Baddi then visit this blog and get information about contract manufacturing in Baddi. http://www.pharmaadda.in/pharma-third-party-manufacturing-companies-in-baddi
Top 10 pharma companies in haridwar | PharmaaddaAditiMehra14
Best pharma companies in haridware is hard to find. Visit Pharmaadda Blog & Find the list of Top 10 pharmaceutical medicine firms in haridware. For more information visit http://www.pharmaadda.in/top-10-pharma-companies-in-haridwar
Access 2-healthcare company introduction deck - english - may 2018Access-2-Healthcare
Market Entry for Medical Technology / Medical Device companies, in Asia Pacific, Europe, US
#Commercialisation
#Healthcare
#Regulatory
#Quality
#SoftwareValidation / #Verification
#DueDiligence
#LicenseHolding
#Go-to-MarketStrategy
#MarketStudies
Pfizer, GE Healthcare, Novartis Pharma and Boehringer-Ingelheim Pharma Confir...Torben Haagh
Want to learn more about how to cover gaps for IDMP implementation until July 1st 2016? Then join experts at the International Conference IDMP Implementation - Impact on Data, Systems and Processes taking place in Berlin from 24 – 25 June 2015.
There are limited places available, so make sure you secure your conference ticket today!
Don't miss this unique opportunity to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
Have a look at our agenda: http://bit.ly/_IDMP_Agenda
Meet GE Healthcare, Pfizer, Novartis Pharma, Boehringer-Ingelheim Pharma and ...Torben Haagh
The leading European conference on the topic of IDMP Implementation - Impact on Data, Systems and Processes is due to take place in Berlin from 24 – 25 June 2015. Don't miss your chance to hear expert presentations, take part in interactive workshops and meet with IDMP experts from around the world including participation from:
• Pfizer Inc. • Boehringer-Ingelheim Pharma GmbH & Co. KG • F. Hoffmann-La Roche Ltd. • Marr Consultancy Ltd • GE Healthcare • A.E.Tiefenbacher GmbH & Co. KG • Bundesinstitut für Arzneimittel und Medizinprodukte • Bundesverband der Arzneimittel-Hersteller e.V. • MEDA Pharma GmbH & Co. KG • Mylan EPD, Inc. • Janssen Pharmaceuticals, Inc. • Novartis Pharma AG and many more.
There are now limited places available, so make sure you secure your conference ticket today! Learn more here:
http://bit.ly/_Agenda-
Azithromycin API Manufacturer in India | PharmaaddaAditiMehra14
In my blog, You can get all the required details about Top 10 Azithromycin API Manufacturer in India. Visit Blog for Top Azithromycin Manufacturers. For more information visit http://www.pharmaadda.in/azithromycin-api-manufacturer-in-india
Similar to Know about Contract manufacturing of pharma products market (20)
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
An introduction to the cryptocurrency investment platform Binance Savings.Any kyc Account
Learn how to use Binance Savings to expand your bitcoin holdings. Discover how to maximize your earnings on one of the most reliable cryptocurrency exchange platforms, as well as how to earn interest on your cryptocurrency holdings and the various savings choices available.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
LA HUG - Video Testimonials with Chynna Morgan - June 2024Lital Barkan
Have you ever heard that user-generated content or video testimonials can take your brand to the next level? We will explore how you can effectively use video testimonials to leverage and boost your sales, content strategy, and increase your CRM data.🤯
We will dig deeper into:
1. How to capture video testimonials that convert from your audience 🎥
2. How to leverage your testimonials to boost your sales 💲
3. How you can capture more CRM data to understand your audience better through video testimonials. 📊
LA HUG - Video Testimonials with Chynna Morgan - June 2024
Know about Contract manufacturing of pharma products market
1.
2. ●
Contract manufacturing of pharma productsContract manufacturing of pharma products facilitatesfacilitates
affordable drugs evolution.affordable drugs evolution.
●
There are many contract manufacturingThere are many contract manufacturing
pharmaceutical company helps clients for easypharmaceutical company helps clients for easy
production, finance, marketing, distribution, andproduction, finance, marketing, distribution, and
management of Pharma products.management of Pharma products.
●
The main purpose of any Pharmaceutical contractThe main purpose of any Pharmaceutical contract
manufacturing Company is to produce cheap andmanufacturing Company is to produce cheap and
best quality Pharmaceutical products withinbest quality Pharmaceutical products within
committed time frame.committed time frame.
3. ●
There are several contract pharmaThere are several contract pharma
manufacturing company in India andmanufacturing company in India and
Worldwide. Most Contract manufacturing ofWorldwide. Most Contract manufacturing of
pharmaceutical products include production ofpharmaceutical products include production of
pills, oral syrups, tablets as well as many otherpills, oral syrups, tablets as well as many other
antibiotic drugs.antibiotic drugs.
4.
5.
6. ●
A growing hundred of Pharma companies are turning toA growing hundred of Pharma companies are turning to
pharmaceutical contract manufacturing services as apharmaceutical contract manufacturing services as a
means of improving their own present business models.means of improving their own present business models.
●
There are plenty of pharmaceutical contractThere are plenty of pharmaceutical contract
manufacturing companies for you to choose from, it'smanufacturing companies for you to choose from, it's
most important to understand that they are not all equal.most important to understand that they are not all equal.
●
Here's a look at few things that you should expect fromHere's a look at few things that you should expect from
the best pharma contract manufacturing companies.the best pharma contract manufacturing companies.
7. ●
A great contract manufacturer will bring multiple servicesA great contract manufacturer will bring multiple services
●
Extensive ExperienceExtensive Experience
●
Up-to-Date ProcessesUp-to-Date Processes
●
Advanced and unique formulationAdvanced and unique formulation
●
Compliant with Industry StandardsCompliant with Industry Standards
●
Meets DeadlinesMeets Deadlines
●
Excellent ReferencesExcellent References
●
Careful Product TestingCareful Product Testing
●
Able to quickly detect to new pharma productsAble to quickly detect to new pharma products
8. ●
Manufacturers are to get economical PharmaManufacturers are to get economical Pharma
products for reducing overall development andproducts for reducing overall development and
management costs. They are also assisting small asmanagement costs. They are also assisting small as
well as medium sized pharmaceutical companies forwell as medium sized pharmaceutical companies for
drugs development and drugs formulation.drugs development and drugs formulation.
●
The cost for drugs production as well as researchThe cost for drugs production as well as research
can also be reduced notably.can also be reduced notably.
●
Moreover, level of services and consumer satisfyMoreover, level of services and consumer satisfy
can also be improved mostly.can also be improved mostly.
9. ●
There are many benefits of pharma contractThere are many benefits of pharma contract
manufacturing. That they usually serve as partnersmanufacturing. That they usually serve as partners
as well as extensions for smaller and virtualas well as extensions for smaller and virtual
organizations that have difficulty in renderingorganizations that have difficulty in rendering
expensive and time-consuming services to theirexpensive and time-consuming services to their
clients.clients.
●
One of biggest benefit of pharma contractOne of biggest benefit of pharma contract
manufacturers is that they are serving as smallmanufacturers is that they are serving as small
virtual organizations for large multinational Pharmavirtual organizations for large multinational Pharma
Companies.Companies.
10.
11. ●
Contract research and manufacturing servicesContract research and manufacturing services
is one of the fastest growing sectors inis one of the fastest growing sectors in
pharmaceutical as well as biotechnologypharmaceutical as well as biotechnology
industry worldwide. The pharma market usesindustry worldwide. The pharma market uses
outsourcing services from low cost providers inoutsourcing services from low cost providers in
the form of contract research organization &the form of contract research organization &
contract manufacturing organizations.contract manufacturing organizations.
12.
13. Yash Complex,167,Kamal Park Society,Yash Complex,167,Kamal Park Society,
B/h Kapodra fire Station,Varachha Road,Surat-394211,(Gujarat), INDIAB/h Kapodra fire Station,Varachha Road,Surat-394211,(Gujarat), INDIA
Email:info@actizapharma.comEmail:info@actizapharma.com
Phone:+91 261 2572050Phone:+91 261 2572050
Website :Website : http://exports.actizapharma.com/